Drug Profile
NanoBarium-3
Latest Information Update: 11 Sep 2006
Price :
$50
*
At a glance
- Originator Sanofi Winthrop
- Class Contrast media
- Mechanism of Action Radiography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gastrointestinal disorders
Most Recent Events
- 11 Sep 2006 Discontinued - Phase-I Gastrointestinal disorders (diagnosis) in European Union (PO)
- 11 Sep 2006 Discontinued - Phase-I Gastrointestinal disorders (diagnosis) in Japan (PO)
- 11 Sep 2006 Discontinued - Phase-I Gastrointestinal disorders (diagnosis) in USA (PO)